Canaccord Genuity Reiterates a 'Buy' on Quidel Corp. (QDEL); Q4 Solid Despite Light Flu; Focus Shifts to New Products

March 1, 2012 10:05 AM EST
Get Alerts QDEL Hot Sheet
Price: $14.74 -0.74%

Rating Summary:
    7 Buy, 10 Hold, 1 Sell

Rating Trend: Up Up

Today's Overall Ratings:
    Up: 8 | Down: 5 | New: 26
Join SI Premium – FREE
Canaccord Genuity reiterates a 'Buy' on Quidel Corp. (NASDAQ: QDEL) price target of $21.00.

Anal yst, Jeffrey Frelick, said, "We reiterate our rating on QDEL as new product contributions start to show up in 2012, with strong contribution occurring in 2013...Future potential drivers. 1) Double the hospital sales force in H1/12, 2) obtain CLIA waiver approval for Sofia flu and strep tests, 3) approval of Amplivue non-instrumented MDx test, and 4) launch Bobcat in Q4/12...Establish 2013 estimates. We introduce our 2013 estimates for QDEL: revenue of $185M and EPS of $0.50."

For an analyst ratings summary and ratings history on Quidel Corp. click here. For more ratings news on Quidel Corp. click here.

Shares of Quidel Corp. closed at $14.18 yesterday.


Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Analyst Comments, Analyst EPS View